Using Kaplan–Meier Plotter website to evaluate the clinical significance of TMCC3 in cancer progression, we showed that higher expression of TMCC3 correlated with poor OS of patients with ovarian, lung, and gastric cancer (Supplementary Fig. S6b). The gene discussed is TMCC3; the disease is gastric cancer.